Revelation Biosciences Stock Today
REVB Stock | USD 2.74 0.31 12.76% |
Performance0 of 100
| Odds Of DistressOver 81
|
Revelation Biosciences is trading at 2.74 as of the 29th of March 2024, a 12.76 percent increase since the beginning of the trading day. The stock's open price was 2.43. Revelation Biosciences has a very high chance of experiencing financial distress in the next few years of operation. It has also generated negative returns for investors over the last 90 days. Equity ratings for Revelation Biosciences are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 28th of February 2024 and ending today, the 29th of March 2024. Click here to learn more.
Business Domain Pharmaceuticals, Biotechnology & Life Sciences | IPO Date 17th of November 2020 | Category Healthcare | Classification Health Care |
Revelation Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of immune system therapeutics and diagnostics. The company was founded in 2020 and is based in San Diego, California. Revelation Biosciences operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. The company has 396.4 K outstanding shares of which 32.78 K shares are at this time shorted by private and institutional investors with about 0.09 trading days to cover. More on Revelation Biosciences
Moving together with Revelation Stock
0.63 | MBRX | Moleculin Biotech Financial Report 9th of May 2024 | PairCorr |
0.79 | MCRB | Seres Therapeutics Financial Report 14th of May 2024 | PairCorr |
0.71 | KA | Kineta Inc Financial Report 9th of May 2024 | PairCorr |
Moving against Revelation Stock
0.89 | MGNX | MacroGenics Financial Report 14th of May 2024 | PairCorr |
0.81 | EQ | Equillium Financial Report 9th of May 2024 | PairCorr |
0.64 | MDWD | Mediwound Downward Rally | PairCorr |
0.61 | CLVRW | Clever Leaves Holdings | PairCorr |
Follow Valuation Profit Patterns Odds of Bankruptcy
Report 4th of April 2024
Revelation Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Revelation Biosciences' investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Revelation Biosciences or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
Business Concentration | Biotechnology, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, NASDAQ Composite, NASDAQ Health Care, Health Care, Biotechnology, Biotechnology, Healthcare (View all Sectors) | ||||
Average Analyst Recommendation Analysts covering Revelation Biosciences report their recommendations after researching Revelation Biosciences' financial statements, talking to executives and customers, or listening in on Revelation Biosciences' conference calls. The current trade recommendation is based on an ongoing consensus estimate among financial analysts covering Revelation Biosciences. The Revelation consensus assessment is calculated by taking the average forecast from all of the analysts covering Revelation Biosciences. | |||||
Revelation Biosciences' financial strength is of vital concern to both outside investors and internal stakeholders. Efficiency and cost control are keys to Revelation Biosciences' success, along with its ability to generate sufficient cash flow to pay bills, repay debt, and make a consistent year-to-year profit. | |||||
Financial leverage usually refers to the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Revelation Biosciences' financial leverage. It provides some insight into what part of Revelation Biosciences' total assets is financed by creditors.
|
Revelation Biosciences (REVB) is traded on NASDAQ Exchange in USA. It is located in 4660 La Jolla Village Drive, San Diego, CA, United States, 92122 and employs 9 people. Revelation Biosciences is listed under Biotechnology category by Fama And French industry classification. The company currently falls under 'Nano-Cap' category with a current market capitalization of 1.09 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Revelation Biosciences's market, we take the total number of its shares issued and multiply it by Revelation Biosciences's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Revelation Biosciences conducts business under Biotechnology sector and is part of Health Care industry. The entity has 396.4 K outstanding shares of which 32.78 K shares are at this time shorted by private and institutional investors with about 0.09 trading days to cover.
Revelation Biosciences currently holds about 3.48 M in cash with (7.29 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.15.
Check Revelation Biosciences Probability Of Bankruptcy
Ownership AllocationRoughly 98.0 pct. of Revelation Biosciences outstanding shares are held by general public with 0.3239999999999999 % owned by insiders and only 1.96 (%) by third-party entities.
Check Revelation Ownership Details
Revelation Stock Price Odds Analysis
What are Revelation Biosciences' target price odds to finish over the current price? Depending on a normal probability distribution, the odds of Revelation Biosciences jumping above the current price in 90 days from now is about 78.94%. The Revelation Biosciences probability density function shows the probability of Revelation Biosciences stock to fall within a particular range of prices over 90 days. Given the investment horizon of 90 days Revelation Biosciences has a beta of -5.5833 indicating as returns on its benchmark rise, returns on holding Revelation Biosciences are expected to decrease by similarly larger amounts. On the other hand, during market turmoils, Revelation Biosciences is expected to outperform its benchmark. Additionally, revelation Biosciences has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming NYSE Composite.
Based on a normal probability distribution, the odds of Revelation Biosciences to move above the current price in 90 days from now is about 78.94 (This Revelation Biosciences probability density function shows the probability of Revelation Stock to fall within a particular range of prices over 90 days) .
Revelation Stock Institutional Holders
Institutional Holdings refers to the ownership stake in Revelation Biosciences that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Revelation Biosciences' outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Revelation Biosciences' value.Instituion | Recorded On | Shares | |
Virtu Financial Llc | 2023-09-30 | 0.0 | |
Hrt Financial Llc | 2023-09-30 | 0.0 | |
Sabby Management Llc | 2023-09-30 | 403.2 K | |
Walleye Trading Advisors, Llc | 2023-09-30 | 391.4 K | |
Citadel Advisors Llc | 2023-09-30 | 57.4 K | |
Axa Sa | 2023-09-30 | 56 K | |
Geode Capital Management, Llc | 2023-09-30 | 35.7 K | |
Tower Research Capital Llc | 2023-09-30 | 2.3 K | |
Cwm, Llc Duplicate | 2023-09-30 | 126 | |
Morgan Stanley - Brokerage Accounts | 2023-09-30 | 123 | |
Ubs Group Ag | 2023-09-30 | 92.0 |
Revelation Biosciences Historical Income Statement
Revelation Biosciences Income Statement is one of the three primary financial statements used for reporting Revelation's overall financial performance over a current year or for a given accounting period. An Income Statement sometimes referred to as the statement of Revelation Biosciences revenue and expense. Revelation Biosciences Income Statement primarily focuses on the company's revenues and expenses during a particular period.
At present, Revelation Biosciences' Total Operating Expenses is projected to decrease significantly based on the last few years of reporting. The current year's Total Other Income Expense Net is expected to grow to about 9 M, whereas Interest Expense is projected to grow to (29.9 K). View More FundamentalsRevelation Stock Against Markets
Picking the right benchmark for Revelation Biosciences stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in Revelation Biosciences stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for Revelation Biosciences is critical whether you are bullish or bearish towards Revelation Biosciences at a given time. Please also check how Revelation Biosciences' historical prices are related to one of the top price index indicators.
Be your own money manager
Our tools can tell you how much better you can do entering a position in Revelation Biosciences without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Portfolio File Import Now
Portfolio File ImportQuickly import all of your third-party portfolios from your local drive in csv format |
All Next | Launch Module |
Revelation Biosciences Corporate Management
Elected by the shareholders, the Revelation Biosciences' board of directors comprises two types of representatives: Revelation Biosciences inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Revelation. The board's role is to monitor Revelation Biosciences' management team and ensure that shareholders' interests are well served. Revelation Biosciences' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Revelation Biosciences' outside directors are responsible for providing unbiased perspectives on the board's policies.
James Rolke | CEO Director | Profile | |
Carol Odle | Director Projects | Profile | |
Chester III | Chief Officer | Profile | |
Sandra Vedrick | Vice Relations | Profile |
How to buy Revelation Stock?
Before investing in Revelation Biosciences, you must ensure you fully understand your financial goals and how diversified (or not) your overall investments are now. Then, after you clearly understand your investment objectives, consider investing in Revelation Biosciences. To buy Revelation Biosciences stock, you can follow these steps:- Choose a brokerage firm: You need to select a brokerage firm to buy shares of Revelation Biosciences. Some popular options include Charles Schwab, Fidelity, TD Ameritrade, and Robinhood.
- Open an account: Once you have chosen a brokerage firm, you will need to open an account. You will be required to provide personal information, such as your name, address, and Social Security number.
- Fund your account: You will need to deposit funds into your brokerage account to purchase Revelation Biosciences stock. You can do this by transferring funds from your bank account or other investment accounts.
- Place your order: Once you have located Revelation Biosciences stock in your brokerage account, you can place your order to buy it. You will need to specify the number of shares you want to buy and the price you are willing to pay.
- Monitor your investment: After you have purchased Revelation Biosciences stock, you should monitor your investment to track its performance and make informed decisions about buying, selling, or holding the stock
It's important to note that investing in stocks, such as Revelation Biosciences, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember various factors, including economic indicators, change in net worth, political events, company-specific news, and investor sentiment, can influence the stock market. These factors can cause fluctuations in stock prices and lead to market volatility affecting your buy or sell decision. However, volatility can also present opportunities for investors to make gains by buying stocks when prices are low and selling when they are high. It's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. For more information on how to buy Revelation Stock please use our How to Invest in Revelation Biosciences guide.
Already Invested in Revelation Biosciences?
The danger of trading Revelation Biosciences is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Revelation Biosciences is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Revelation Biosciences. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Revelation Biosciences is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
When determining whether Revelation Biosciences is a strong investment it is important to analyze Revelation Biosciences' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Revelation Biosciences' future performance. For an informed investment choice regarding Revelation Stock, refer to the following important reports: Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Revelation Biosciences. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in real. For information on how to trade Revelation Stock refer to our How to Trade Revelation Stock guide.You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.
Complementary Tools for Revelation Stock analysis
When running Revelation Biosciences' price analysis, check to measure Revelation Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Revelation Biosciences is operating at the current time. Most of Revelation Biosciences' value examination focuses on studying past and present price action to predict the probability of Revelation Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Revelation Biosciences' price. Additionally, you may evaluate how the addition of Revelation Biosciences to your portfolios can decrease your overall portfolio volatility.
ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
Commodity Directory Find actively traded commodities issued by global exchanges | |
Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios |
Is Revelation Biosciences' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Revelation Biosciences. If investors know Revelation will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Revelation Biosciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.60) | Return On Assets (0.61) | Return On Equity (0.03) |
The market value of Revelation Biosciences is measured differently than its book value, which is the value of Revelation that is recorded on the company's balance sheet. Investors also form their own opinion of Revelation Biosciences' value that differs from its market value or its book value, called intrinsic value, which is Revelation Biosciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Revelation Biosciences' market value can be influenced by many factors that don't directly affect Revelation Biosciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Revelation Biosciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Revelation Biosciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Revelation Biosciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.